关注
Arshid Yousefi Avarvand
Arshid Yousefi Avarvand
在 ajums.ac.ir 的电子邮件经过验证
标题
引用次数
引用次数
年份
Are chitosan natural polymers suitable as adjuvant/delivery system for anti-tuberculosis vaccines?
F Khademi, RA Taheri, AY Avarvand, H Vaez, AA Momtazi-Borojeni, ...
Microbial pathogenesis 121, 218-223, 2018
632018
Multi-stage subunit vaccines against Mycobacterium tuberculosis: an alternative to the BCG vaccine or a BCG-prime boost?
F Khademi, M Derakhshan, A Yousefi-Avarvand, M Tafaghodi, ...
Expert review of vaccines 17 (1), 31-44, 2018
562018
The frequency of exotoxin A and exoenzymes S and U genes among clinical isolates of Pseudomonas aeruginosa in Shiraz, Iran
A Yousefi-Avarvand, R Khashei, HS Ebrahim-Saraie, A Emami, ...
International journal of molecular and cellular medicine 4 (3), 167, 2015
532015
Potential of polymeric particles as future vaccine delivery systems/adjuvants for parenteral and non-parenteral immunization against tuberculosis: A systematic review
F Khademi, M Derakhshan, A Yousefi-Avarvand, M Tafaghodi
Iranian journal of basic medical sciences 21 (2), 116, 2018
322018
Antibiotic Resistance of Helicobacter pylori in Iranian Children: A Systematic Review and Meta-Analysis
A Yousefi-Avarvand, H Vaez, M Tafaghodi, AH Sahebkar, M Arzanlou, ...
Microbial Drug Resistance 24 (7), 980-986, 2018
292018
A novel antigen of Mycobacterium tuberculosis and MPLA adjuvant co-entrapped into PLGA: DDA hybrid nanoparticles stimulates mucosal and systemic immunity
F Khademi, M Derakhshan, A Yousefi-Avarvand, A Najafi, M Tafaghodi
Microbial pathogenesis 125, 507-513, 2018
262018
Effect of Helicobacter Pylori eradication on patients with ITP: a meta-analysis of studies conducted in the Middle East
SMS Pezeshki, N Saki, MV Ghandali, A Ekrami, AY Avarvand
Blood research 56 (1), 38-43, 2021
202021
Prevalence of antibiotic resistance of Haemophilus Influenzae in Iran-a meta-analysis
H Vaez, A Sahebkar, F Pourfarzi, A Yousefi-Avarvand, F Khademi
Iranian journal of otorhinolaryngology 31 (107), 349, 2019
192019
HspX protein as a candidate vaccine against Mycobacterium tuberculosis: an overview
A Yousefi-Avarvand, M Tafaghodi, S Soleimanpour, F Khademi
Frontiers in Biology 13, 293-296, 2018
192018
Mycobacterium tuberculosis HspX/EsxS fusion protein: gene cloning, protein expression, and purification in Escherichia coli
F Khademi, A Yousefi-Avarvand, M Derakhshan, Z Meshkat, M Tafaghodi, ...
Reports of Biochemistry & Molecular Biology 6 (1), 15, 2017
172017
Enhancing immunogenicity of novel multistage subunit vaccine of Mycobacterium tuberculosis using PLGA: DDA hybrid nanoparticles and MPLA: Subcutaneous administration
F Khademi, A Yousefi, M Derakhshan, A Najafi, M Tafaghodi
Iranian Journal of Basic Medical Sciences 22 (8), 893, 2019
152019
Assessing the Potential Biological Activities of Postbiotics Derived from Saccharomyces cerevisiae: An In Vitro Study
H Hosseini, A Abbasi, S Sabahi, S Akrami, A Yousefi-Avarvand
Probiotics and Antimicrobial Proteins, 1-17, 2023
112023
Middle east Mycobacterium tuberculosis antibiotic resistance: a systematic review and meta-analysis
F Khademi, A Yousefi-Avarvand, M Derakhshan, H Vaez, R Sadeghi
Infection Epidemiology and Microbiology 3 (1), 25-35, 2017
102017
Bacterial etiology and antibiotic susceptibility pattern of female patients with urinary tract infection referred to Imam Khomeini Hospital, Ahvaz, Iran, 2019
S Akrami, R Abouali, MM Olapour, RHL Abady, H Yazdaninejad, ...
Journal of Current Biomedical Reports 1 (1), 23-6, 2020
92020
Evaluating inhibitory effects of paclitaxel and vitamin D3 loaded poly lactic glycolic acid co-delivery nanoparticles on the breast cancer cell line
S Khodaverdi, A Jafari, F Movahedzadeh, F Madani, AY Avarvand, ...
Advanced Pharmaceutical Bulletin 10 (1), 30, 2020
92020
Formulation and optimization of a new cationic lipid-modified PLGA nanoparticle as delivery system for Mycobacterium tuberculosis HspX/EsxS fusion protein: an experimental design
F Khademi, A Yousefi-Avarvand, M Derakhshan, MR Abbaspour, K Sadri, ...
Iranian Journal of Pharmaceutical Research: IJPR 18 (1), 446, 2019
92019
Drug resistance of clinical and environmental isolates of Brucella species in Iran: a meta-analysis
F Khademi, A Yousefi-Avarvand, A Sahebkar, B Mohammadi-Ghalehbin, ...
Reviews and Research in Medical Microbiology 29 (4), 166-172, 2018
92018
Immunogenicity of HspX/EsxS fusion protein of Mycobacterium tuberculosis along with ISCOMATRIX and PLUSCOM nano-adjuvants after subcutaneous administration in animal model
AY Avarvand, Z Meshkat, F Khademi, M Tafaghodi
Microbial Pathogenesis 154, 104842, 2021
82021
The roles of latency-associated antigens in tuberculosis vaccines
ZM Arshid Yousefi Avarvand, Farzad Khadem,Mohsen Tafaghodi, Zahra Ahmadipour ...
Indian journal of tuberculosis, 2019
72019
A systematic review and meta-analysis on the epidemiology of antibiotic resistance of Vibrio cholerae in Iran.
A Yousefi, H Vaez, A Sahebkar, F Khademi
Annali di Igiene, Medicina Preventiva e di Comunità 31 (4), 2019
62019
系统目前无法执行此操作,请稍后再试。
文章 1–20